Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Covance is a top CRO company, dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
Turning Biorepositories into Translational Science Treasure Troves: The Value of Uniquely Complete Data Sets | May 4, 2017 - 11 a.m. EDT
Amelia Warner, PharmD, RPh, CEO and Founder, Global Specimen Solutions, Inc., will discuss how biorepositories represent an increasingly valuable resource for translational science stemming from data generated through the increasing number of biomarker assays available for use in clinical trials as well as wider patient populations around the globe.
Advances in Immuno-Oncology Congress
May 15-16 in London
Don't miss Covance Chief Scientific Officer, Steve Anderson, PhD, as he speaks about the role of biomarkers and companion diagnostics in immuno-oncology. Register now.
Rare and Orphan Diseases Patient Perceptions: Implications for Recruitment, Retention and Compliance in Clinical Trials |
May 4, 2017 - 11 a.m. EDT
Do you face the challenge of recruiting and retaining rare disease patients for orphan drug clinical trials? Now, discover how you can boost participation, enhance outcomes and speed drug development in this competitive market. Register today.
Stepping Up the Game: MMRV Concomitant Testing Support for Vaccine Evaluation
Find out how to support aggressive development pipelines by leveraging tailored non-inferiority studies to meet your global vaccine evaluation needs.
Rare Disease and Orphan Drugs: accelerate complex studies globally
A range of individual approaches can be integrated to accelerate your progress of complex rare disease studies across the world. Learn how to address key development challenges.
The diabetic heart: A focus on heart failure recording now available
Hear an insightful discussion on how certain molecular classes impact CV outcomes for patients with type 2 diabetes along with strategies for testing new therapeutic, paradigm-modifying treatment modalities.
The biosimilars landscape: What all developers need to know recording now available
The regulatory pathway for developing biosimilars in the U.S. is still considered a new frontier. View this webinar as we discuss the key clinical issues sponsors face when navigating today’s regulatory environment.
Meet Covance Market Access at Asembia Specialty Pharmacy Summit | April 30-May 3, 2017
How do YOU measure success? Experience Forward Thinking With Covance Market Access Booth 711, #Asembia 17
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
Implementing basket/bucket and umbrella designs: What you need to know for global oncology trials | May 8, 2017
Immuno-oncology and the role of biomarkers, companion and complementary diagnostics
Learn more about how the use of a variety of biomarkers, companion diagnostics (CDx) and complementary diagnostics has powered the recent evolution of immunotherapies and their potential applications.
Have you visited the NASH Education Center?
We’re pleased to announce the launch of the NASH Education Center. Access the latest thoughts from experts through webinars, case studies, blogs, info sheets and scientific articles.
Virtual Clinic Tour
Go inside our Madison Clinical Research Unit
On-campus radioanalysis means faster results and deep insights into drug metabolism. Learn more by touring our Madison CRU.